| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.57B | 27.86B | 11.57B | 10.14B | 8.75B | 8.12B |
| Gross Profit | 5.66B | 11.62B | 5.70B | 5.22B | 4.53B | 4.47B |
| EBITDA | 3.43B | 5.98B | 3.11B | 2.62B | 8.69B | 3.05B |
| Net Income | 1.67B | 3.07B | 1.65B | 1.59B | 5.44B | 1.45B |
Balance Sheet | ||||||
| Total Assets | 16.89B | 53.03B | 18.26B | 18.63B | 21.36B | 14.06B |
| Cash, Cash Equivalents and Short-Term Investments | 2.91B | 22.70B | 4.01B | 3.64B | 2.14B | 5.18B |
| Total Debt | 218.76M | 103.46M | 247.20M | 274.57M | 303.29M | 138.18M |
| Total Liabilities | 2.40B | 11.10B | 2.85B | 2.52B | 4.56B | 1.78B |
| Stockholders Equity | 14.35B | 32.63B | 15.24B | 15.96B | 16.48B | 11.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.64B | 2.00B | 8.34B | 2.27B | 804.63M |
| Operating Cash Flow | 0.00 | 2.68B | 2.01B | 8.76B | 2.61B | 1.13B |
| Investing Cash Flow | 0.00 | -910.18M | 359.58M | -5.49B | -3.47B | 1.32B |
| Financing Cash Flow | 0.00 | -2.19B | -2.01B | -2.15B | -1.89B | -2.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥69.64B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
72 Outperform | ¥83.11B | 13.86 | 10.06% | 3.75% | 140.81% | 54.07% | |
70 Outperform | ¥200.00B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥233.66B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
43 Neutral | ¥167.32B | 13.27 | 7.26% | 4.16% | 9.77% | -52.42% | |
42 Neutral | ¥4.95B | -56.21 | ― | ― | -2.83% | 97.23% |